In December, Rockies pitcher Chad Bettis revealed that he underwent surgery for testicular cancer. In January it was reported that he was cancer free and that he’d report to Rockies camp in Scottsdale as scheduled.
Unfortunately, that report was premature: Bettis is leaving spring training to undergo chemotherapy after discovering that his testicular cancer has spread. There is no timetable for his return.
Bettis, who turns 28 next month, was expected to be at the top of the Rockies’ rotation this season after going 14-8 with a 4.79 ERA in 32 starts in 2016. That’s unimportant now. All that matters is that he get better.
Good luck, Chad.
ESPN’s Jeff Passan reports that the Rockies and shortstop Trevor Story have come to terms on a two-year, $27.5 million deal, buying out his two remaining years of arbitration eligibility.
Story, 27, and the Rockies did not agree on a salary before the deadline earlier this month. Story filed for $11.5 million while the team countered at $10.75 million. The average annual value of this deal — $13.75 million — puts him a little bit ahead this year and likely a little bit behind next year.
This past season in Colorado, Story hit .294/.363/.554 with 35 home runs, 85 RBI, 111 runs scored, and 23 stolen bases over 656 trips to the plate. He also continued to rank among the game’s best defensive shortstops. Per FanGraphs, Story’s 10.9 Wins Above Replacement over the last two seasons is fifth-best among shortstops (min. 1,000 PA) behind Alex Bregman, Francisco Lindor, Xander Bogaerts, and Marcus Semien.
With third baseman Nolan Arenado likely on his way out via trade, one wonders if the same fate awaits Story at some point over the next two seasons.